Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Maitreya Medicare Ltd (MAITREYA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: MAITREYA Hospital & Healthcare Services | Small Cap | Maitreya Medicare Share Price
BSE Share Price
Not Listed
Not Listed
Maitreya Medicare Ltd (MAITREYA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: MAITREYA Hospital & Healthcare Services | Small Cap | Maitreya Medicare Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹76 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹-3.6
TTM Sales
₹44.9 Cr.
Book Value per Share
₹35.8
P/E Ratio
0.00
Lower than its 5-year historical median
Industry PE
98.6
Price to Book (P/B)
3.13
Lower than its 5-year historical median
Price to Sales (P/S)
1.69
Lower than its 5-year historical median
EV/EBITDA
136.43
Higher than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
-9.67%
Underperforms industry median
Return on Capital Employed (ROCE)
-2.04%
Underperforms industry median
Return on Assets (ROA)
-4.23%
Operating Profit Margin
-0.6%
Net Profit Margin
-5.5%
Gross Profit Margin
-1.9%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-0.43%
Operating Profit Growth (1 Year)
-
-106.56%
Net Profit Growth (1 Year)
-
-235.71%
Asset Quality
Promoter Holding
73.11%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹17 Cr.
Equity
₹6.8 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Maitreya Medicare Ltd a good quality company?
Maitreya Medicare Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Maitreya Medicare Ltd performance compare with that of its Peers?
Revenue growth of Maitreya Medicare Ltd vs industry peers?
Maitreya Medicare Ltd revenue CAGR is -4.55%, compared to the industry median CAGR of 0%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of Maitreya Medicare Ltd?
Promoters hold 73.11% of the Maitreya Medicare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Maitreya Medicare Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of -54.77% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Maitreya Medicare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|
| ROCE % ⓘ | 31.5% | 18.8% | 12.5% | 1.4% | - |
| Value Creation Index ⓘ | 1.3 | 0.3 | -0.1 | -0.9 | - |
Growth Parameters ⓘ |
|||||
| Sales ⓘ | 38.5 | 46.5 | 44.4 | 44.2 | 44 |
| Sales YoY Gr. | - | 20.9% | -4.6% | -0.4% | - |
| Adj EPS ⓘ | 8.4 | 4.7 | 2.8 | -1.9 | -2 |
| YoY Gr. | - | -44.6% | -40.3% | -168.4% | - |
| BVPS (₹) ⓘ | 17.7 | 36.7 | 39.5 | 37.5 | 37.5 |
| Adj Net Profit ⓘ | 4.2 | 3.2 | 1.9 | -1.3 | -1 |
| Cash Flow from Ops. ⓘ | 2.4 | -0.3 | 5 | 5.5 | - |
| Debt/CF from Ops. ⓘ | 2.4 | -15.7 | 0.7 | 4.2 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | 4.7% | -0.4% | ||||
| Adj EPS ⓘ | NA | NA | -160.9% | -168.4% | ||||
| BVPSⓘ | NA | NA | 28.5% | -4.9% | ||||
| Share Price | - | - | - | -54.8% | ||||
Key Financial Parameters ⓘ
| Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|
| Return on Equity % ⓘ | 28.7 | 14.1 | 6 | -4.1 | -5.2 |
| Op. Profit Mgn % ⓘ | 18.6 | 13.2 | 11.9 | 3 | 12 |
| Net Profit Mgn % ⓘ | 10.8 | 6.8 | 4.2 | -2.9 | -3 |
| Debt to Equity ⓘ | 0.4 | 0.1 | 0.1 | 0.8 | - |
| Working Cap Days ⓘ | 0 | 135 | 178 | 176 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 40 | 75 | 67 | 0 |
Valuation of Maitreya Medicare - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|
| Sales | 56.61 | 49.41 | 39.38 | 47.76 | 46.66 | 44.85 |
| Operating Expenses ⓘ + | 49.37 | 46.05 | 32.13 | 41.76 | 41.78 | 45.17 |
| Operating Profit ⓘ | 7.24 | 3.36 | 7.25 | 6 | 4.88 | -0.32 |
| Operating Profit Margin (%) | 12.8% | 6.8% | 18.4% | 12.6% | 10.5% | -0.7% |
| Other Income ⓘ + | 0.43 | 0.33 | 0.57 | 0.27 | 0.57 | 0.99 |
| Interest ⓘ | 0.82 | 0.78 | 0.57 | 0.84 | 0.80 | 1.49 |
| Depreciation ⓘ | 1.09 | 1.32 | 1.29 | 1.27 | 1.50 | 1.52 |
| Profit Before Tax ⓘ | 5.77 | 1.60 | 5.93 | 4.18 | 3.16 | -2.41 |
| Tax ⓘ | 1.53 | 0.46 | 1.67 | 1.22 | 1.34 | 0.06 |
| Profit After Tax | 4.24 | 1.14 | 4.25 | 2.97 | 1.82 | -2.47 |
| PAT Margin (%) | 7.5% | 2.3% | 10.8% | 6.2% | 3.9% | -5.5% |
| Adjusted EPS (₹) | 8.6 | 2.3 | 8.0 | 3.9 | 2.7 | -3.6 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 8.91 | 9.59 | 14.51 | 30.24 | 32.04 | 29.03 | |||||
| Debt + | 8 | 6.26 | 5.85 | 5.70 | 5.21 | 23.12 | |||||
| Minority Interest | 0.68 | 1.28 | 1.03 | 0.11 | 0.82 | 0.75 | |||||
| Trade Payables | 5.14 | 3.75 | 3.66 | 3.14 | 3.22 | 4.01 | |||||
| Others Liabilities ⓘ | 2.53 | 3.60 | 3.86 | 4.66 | 6.71 | 11.53 | |||||
| Total Liabilities ⓘ | 25.27 | 24.49 | 28.91 | 43.86 | 47.99 | 68.44 | |||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 13.84 | 13.40 | 11.60 | 14.32 | 15.26 | 40.81 | |||||
| CWIP ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Investments ⓘ | 1.07 | 0.32 | 0.68 | 1.47 | 0.04 | 0.05 | |||||
| Inventories | 1.37 | 0.69 | 0.80 | 0.61 | 0.59 | 0.84 | |||||
| Trade Receivables | 4.89 | 5.87 | 9.73 | 13.70 | 14.96 | 11.02 | |||||
| Cash Equivalents | 2.91 | 1.15 | 1.94 | 6.56 | 7.92 | 8.67 | |||||
| Others Assets ⓘ | 1.20 | 3.05 | 4.16 | 7.21 | 9.23 | 7.04 | |||||
| Total Assets ⓘ | 25.27 | 24.49 | 28.91 | 43.86 | 47.99 | 68.44 | |||||
| PARTICULARS | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 4.45 | 0.08 | 2.59 | -2.50 | 5.06 | 8.06 |
| Cash Flow From Investing Activity ⓘ + | -5.07 | -0.02 | 0.36 | -5.44 | -7.37 | -26.74 |
| Cash Flow From Financing Activity ⓘ + | 2.16 | -1.86 | -1.59 | 12.21 | 3.67 | 19.04 |
| Net Cash Flow ⓘ | 1.55 | -1.80 | 1.36 | 4.27 | 1.36 | 0.36 |
| PARTICULARS | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 109.87 | 26.51 | 63.08 | 17.67 | 7.05 | -9.67 | ||||
| ROCE (%) | 36.39 | 13.48 | 34.68 | 17.86 | 10.82 | -2.04 | ||||
| Asset Turnover Ratio | 2.24 | 1.99 | 1.47 | 1.31 | 1.02 | 0.77 | ||||
| PAT to CFO Conversion(x) | 1.05 | 0.07 | 0.61 | -0.84 | 2.78 | N/A | ||||
| Working Capital Days | ||||||||||
| Receivable Days | 31.50 | 39.80 | 72.30 | 89.50 | 112.10 | 105.70 | ||||
| Inventory Days | 8.80 | 7.60 | 6.90 | 5.40 | 4.70 | 5.80 | ||||
| Payable Days | 194.20 | 144.70 | 279.60 | 194.80 | 178 | 158 | ||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Maitreya Medicare Ltd FAQs
The current trading price of Maitreya Medicare on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Maitreya Medicare stood at ₹75.99 Cr
The latest P/E ratio of Maitreya Medicare as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Maitreya Medicare as of 31-Dec-1969 is 2.99.
The 52-week high of Maitreya Medicare is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Maitreya Medicare is ₹44.22 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Maitreya Medicare Ltd is a average quality company.
The key valuation ratios of Maitreya Medicare Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Maitreya Medicare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Maitreya Medicare Ltd
The company was originally incorporated as ‘Maitreya Medicare Private Limited’ a private limited company under the Companies Act, 2013 at Surat Gujarat, pursuant to a certificate of incorporation dated March 28, 2019, issued by the Registrar of Companies, Central Registration Centre (CRC) (RoC). Thereafter, name of the Company was changed from ‘Maitreya Medicare Private Limited’ to ‘Maitreya Medicare Limited’, consequent to conversion of the Company from private to public company, pursuant to a special resolution passed by the shareholders of the Company on March 06, 2023, and a fresh certificate of incorporation consequent to change of name was issued by the RoC on March 30, 2023.
Maitreya Medicare (MML) is a Multi Superspeciality hospital incorporated in the year 2019 based out in Surat, Gujarat. The company provides multi disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care. The company strives to provide quality service to more patients and it has scope for additional patients and improved occupancy rates. The company strategically focuses on the southern Gujarat healthcare market where it has a strong understanding of regional nuances, customer culture and the mind set of medical professionals and where there is a growing need for quality and affordable healthcare services. Its hospital also has integrated diagnostic services and pharmacies that cater to its patients.
The company follow a ‘patient first’ ideology by creating the good infrastructure with thrust on service delievery to all its stake holders, be it patient, staff or doctors, technology and support to put patient-first and foremost and be futuristic and innovative in the delivery of healthcare services. Patients are the key stakeholders in the healthcare industry everything revolves around patients’ comfort, their convenience in all respects should always be maintained. Its hospital is located in densely populated micro market with a low presence of good-quality hospitals, which provides it an opportunity to offer its services to a larger population and help its patients with greater access and connectivity to healthcare services. Its hospital being a full service hospital, operates independently serving the healthcare needs of patients, right from diagnostics to surgery and rehabilitation. It focuses on promoting and maintaining a culture that encourages the retention and growth of its healthcare professionals also.
Business area of the company
The company offers a comprehensive range of healthcare services across many specialities and super specialities, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
Award and Accreditation
- 2022: Maitreya Medicare received the National Accredation Board for Hospitals & Healthcare Providers (NABH) accredation by the NABH Board of India.
Major events
- 2019: Established and commenced operations of the company’s first Hospital at Surat, Gujarat.
- 2021: Maitreya Medicare expanded for B Wing and converted into 125 beds from 100 beds.
- 2022: Obtained Certificate of Accreditation from National Accredation Board for Hospitals & Healthcare Providers (NABH).
- 2023: Conversion of the company from private limited to public limited.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
